NET PROFIT (x1000 EUR)
EMPLOYEES
Billev Pharma ApS
Closing information (x1000 EUR)
| Closing information | 2024/04 | 2023/04 | 2022/04 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
582
|
851
|
1,038 |
| Total assets |
927
|
1,200
|
1,392 |
| Current assets |
925
|
1,200
|
1,392 |
| Current liabilities |
339
|
300
|
331 |
| Equity capital |
496
|
706
|
851 |
| - share capital |
43
|
43
|
43 |
| Employees (average) |
15
|
15
|
15 |
Financial ratios
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Solvency |
53.5%
|
58.8%
|
61.1% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
272.9%
|
400%
|
420.5% |
| Return on equity (ROE) |
117.3%
|
120.5%
|
122.0% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.